Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$213M |
| 2 |
Altria Group
MO
|
+$206M |
| 3 |
ExxonMobil
XOM
|
+$105M |
| 4 |
Microsoft
MSFT
|
+$86.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$75.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$403M |
| 2 |
Home Depot
HD
|
+$164M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$160M |
| 4 |
Boeing
BA
|
+$127M |
| 5 |
Hewlett Packard
HPE
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 14.35% |
| 4 | Industrials | 10.62% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Genasys
GNSS
$58.7M
| $242K | ﹤0.01% |
143,413
| – | – |
2013 Q2
16 quarters
|
|
3552
inTEST
INTT
$167M
| $242K | ﹤0.01% |
36,180
| – | – |
2013 Q2
16 quarters
|
|
|
SMED
3553
DELISTED
Sharps Compliance Corp
SMED
| $242K | ﹤0.01% |
57,439
-2,602
| -4% | -$11.1K |
2013 Q2
16 quarters
|
|
3554
Frequency Electronics
FEIM
$789M
| $241K | ﹤0.01% |
25,327
-1,597
| -6% | -$16.1K |
2013 Q2
16 quarters
|
|
3555
Enphase Energy
ENPH
$4.07B
| $240K | ﹤0.01% |
277,732
-4,104
| -1% | -$4.06K |
2013 Q2
16 quarters
|
|
3556
Lightpath Technologies
LPTH
$574M
| $240K | ﹤0.01% |
88,989
+21,634
| +32% | +$60.7K |
2013 Q2
16 quarters
|
|
3557
Natural Alternatives International
NAII
$7.02M
| $239K | ﹤0.01% |
23,978
+1,503
| +7% | +$14.9K |
2013 Q2
16 quarters
|
|
3558
DELISTED
Adverum Biotechnologies
ADVM
| $238K | ﹤0.01% |
9,525
-4,001
| -30% | -$109K |
2014 Q3
11 quarters
|
|
3559
Greene County Bancorp
GCBC
$583M
| $238K | ﹤0.01% |
+17,528
| New | +$216K |
2017 Q2
0 quarters
|
|
3560
NanoViricides
NNVC
$35M
| $237K | ﹤0.01% |
8,799
| – | – |
2013 Q4
14 quarters
|
|
3561
DELISTED
B Communications Ltd
BCOM
| $237K | ﹤0.01% |
13,809
+3,764
| +37% | +$74.3K |
2015 Q4
6 quarters
|
|
|
NVLN
3562
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $237K | ﹤0.01% |
+25,722
| New | +$248K |
2017 Q2
0 quarters
|
|
|
ANCB
3563
DELISTED
Anchor Bancorp
ANCB
| $237K | ﹤0.01% |
9,419
-445
| -5% | -$11.1K |
2016 Q3
3 quarters
|
|
3564
Amplify Energy
AMPY
$180M
| $235K | ﹤0.01% |
+18,563
| New | +$313K |
2017 Q2
0 quarters
|
|
3565
BBVA Argentina
BBAR
$2.64B
| $235K | ﹤0.01% |
12,438
-337
| -3% | -$6.3K |
2016 Q3
3 quarters
|
|
3566
EyePoint Inc
EYPT
$271M
| $235K | ﹤0.01% |
13,748
-557
| -4% | -$10.6K |
2013 Q2
16 quarters
|
|
|
FCSC
3567
DELISTED
Fibrocell Science Inc.
FCSC
| $235K | ﹤0.01% |
11,742
-343
| -3% | -$4.23K |
2013 Q3
15 quarters
|
|
3568
Inspired Entertainment
INSE
$89.4M
| $234K | ﹤0.01% |
+18,031
| New | +$200K |
2017 Q2
0 quarters
|
|
3569
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $234K | ﹤0.01% |
1,799
+1,050
| +140% | +$142K |
2016 Q3
3 quarters
|
|
3570
Actinium Pharmaceuticals
ATNM
$33.3M
| $233K | ﹤0.01% |
6,375
+1,332
| +26% | +$55.7K |
2014 Q2
12 quarters
|
|
3571
Enterprise Products Partners
EPD
$76.8B
| $233K | ﹤0.01% |
8,610
| – | – |
2016 Q2
4 quarters
|
|
3572
Woori Financial
WF
$17.2B
| $233K | ﹤0.01% |
+4,787
| New | +$199K |
2017 Q2
0 quarters
|
|
3573
PAR Technology
PAR
$718M
| $232K | ﹤0.01% |
27,309
| – | – |
2013 Q2
16 quarters
|
|
|
ATAXZ
3574
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $232K | ﹤0.01% |
39,141
-1,437
| -4% | -$8.52K |
2014 Q1
13 quarters
|
|
|
SVA
3575
DELISTED
Sinovac Biotech, Ltd
SVA
| $232K | ﹤0.01% |
34,487
-4,989
| -13% | -$27.3K |
2013 Q4
14 quarters
|
|
Similar funds
Geode Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Geode Capital Management held 4,218 positions worth $254B, up 4.3% from $244B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Geode Capital Management's Q2 2017 filing shows 134 new, 2,755 increased, 887 reduced and 134 closed positions. Its largest new stake was DXC Technology: 3,214,073 shares worth $213M. The largest sale was Yahoo Inc, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2017 buy was DXC Technology: 3,214,073 shares worth $213M.
- Geode Capital Management added most to Altria Group in Q2 2017, an estimated $206M increase.
- Geode Capital Management's biggest Q2 2017 reduction was Home Depot, cutting an estimated $164M.
- Geode Capital Management fully exited Yahoo Inc in Q2 2017, selling an estimated $403M.
- Geode Capital Management's ten largest holdings make up 16% of its $254B portfolio in Q2 2017.
- Geode Capital Management opened 134 new positions and closed 134 in Q2 2017.
- Geode Capital Management's portfolio value rose 4.3% quarter-over-quarter to $254B.
Based on Geode Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.